CASI Pharmaceuticals, Inc. (CASI) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Cash from Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -843K | -6.52M | -9.48M | -4.24M | -7.64M | -3.86M | -7.34M | -8M | -8.03M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | -5.52% | -63.88% | -110.61% | -46.77% | -83.44% | -47.58% | -102.49% | -139.49% | -166.57% |
| Operating CF Growth % | - | - | - | - | - | - | - | 100% | 100% | 100% | 100% | 88.97% | -69.02% | -29.2% | 47.03% | 4.87% | 43.48% | -14.87% | -72.66% | -66.71% |
| Net Income | -10.88M | -13.38M | -10.75M | -14.37M | -8.39M | -6.96M | -9.53M | -6.05M | -4.63M | -10.24M | -6.01M | -19.34M | -5.02M | -7.49M | -8.4M | -5.39M | -10.22M | -6.74M | -13.68M | -14.2M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 890K | 765K | 334K | 433K | 413K | 765K | 465K | 516K | 774K |
| Stock-Based Compensation | 0 | 0 | 0 | 1.31M | 0 | 0 | 0 | 7.22M | 0 | 0 | 0 | 1.42M | 1.76M | 1.92M | 1.91M | 2.71M | 0 | 1.04M | 2M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.87M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 10.88M | 13.38M | 10.75M | 13.06M | 8.39M | 6.96M | 9.53M | -1.16M | 4.63M | 10.24M | 6.01M | 13.48M | -449K | 1.49M | 1.86M | 249K | 5.44M | 410K | 4.28M | 5.46M |
| Working Capital Changes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.7M | -3.58M | -5.74M | -42K | 246K | 158K | -2.51M | -1.11M | -66K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -413K | -2.3M | -174K | -283K | -4.38M | 349K | 71K | -1.19M | -567K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -365K | 18K | -2.07M | -1.81M | -180K | 1.75M | -481K | -1.64M | -636K |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.14M | -1.31M | -2.14M | 2.38M | 1.47M | -858K | -1.19M | 2.07M | 894K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17.95M | 16.45M | -961K | -2.29M | -4.74M | -2.91M | -977K | -12.07M | -12.57M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.43M | -467K | 569K | -2.29M | -5.21M | -2.52M | -227K | -981K | -1.13M |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | 22.45% | 4.57% | 6.64% | 25.25% | 56.94% | 31.09% | 3.17% | 17.1% | 23.48% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.29M | 0 | 1.29M | 0 | 0 | 10K | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.73M | 0 | -1.16M | 0 | -5.11M | 0 | -750K | -5.5M | -5.12M |
| Cash from Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.27M | 2M | 1M | -3M | -1.08M | -463K | 0 | 31.19M | 765K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3M | 2M | 1M | 0 | -1.08M | -463K | 0 | 709K | 783K |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -267K | 0 | 0 | -3M | 0 | 0 | 0 | 32.5M | -18K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -267K | 0 | 0 | -3M | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.02M | 0 |
| Net Change in Cash | -2.06M | -4.16M | -2.57M | -3.07M | 7M | -2.67M | -4.88M | -2.89M | 3.06M | 322K | -30.52M | 17.87M | 10.38M | -10.4M | -9.45M | -14.42M | -7.23M | -7.76M | 11.05M | -17.53M |
| Free Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.27M | -6.99M | -8.91M | -6.53M | -12.86M | -6.38M | -8.32M | -14.48M | -9.16M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | -27.98% | -68.45% | -103.98% | -72.02% | -140.38% | -78.67% | -116.13% | -252.48% | -190.05% |
| FCF Growth % | - | - | - | - | - | - | - | 100% | 100% | 100% | 100% | 66.79% | -9.54% | -7.18% | 54.94% | -40.29% | 63.93% | -9.82% | -212.45% | 27.26% |
| FCF per Share | - | - | - | - | - | - | - | - | - | - | - | -0.32 | -0.51 | -0.66 | -0.47 | -0.93 | -0.46 | -0.59 | -1.16 | -0.78 |
| FCF Conversion (FCF/Net Income) | - | - | - | - | - | - | - | - | - | - | - | 0.04x | 1.25x | 1.23x | 0.49x | 1.36x | 0.38x | 1.06x | 0.58x | 0.57x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |